Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers. Issue 4 (June 2015)

• Record Type: Journal Article
• Authors: Feng, Qin; Baker, Susan S.; Liu, Wensheng; Arbizu, Ricardo A.; Aljomah, Ghanim; Khatib, Maan; Nugent, Colleen A.; Baker, Robert D.; Forte, Trudy M.; Hu, Yiyang; Zhu, Lixin
• Is Part Of: Pathology. Volume 47:Issue 4(2015:Jun.)
• Publication Date: 2015-06
• Subjects: Pathology -- Periodicals; 616.0705
• DOI: 10.1097/PAT.0000000000000251
• Languages: English
• ISSNs: 0031-3025

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Summary</title> <p>Apolipoprotein A5 (apoA5) is a potent regulator of triglyceride (TG) metabolism and therefore may contribute to the pathogenesis of non-alcoholic fatty liver disease (NAFLD), a disease characterised by excessive TG-rich lipid droplets in hepatocytes. To test this hypothesis, we examined the mRNA expression of apoA5 in paediatric NAFLD livers in comparison to healthy controls. According to microarray and quantitative real-time PCR, human NAFLD livers exhibited elevated apoA5 expression compared to healthy controls. The apoA5 expression levels were positively correlated with hepatic TG storage and a marker for lipid droplets (perilipin), but were not correlated with plasma TG levels. These observations were confirmed with a NAFLD rat model. Interestingly, apoA5 expression was not altered in cultured fat-laden HepG2 cells, demonstrating that fat storage does not induce apoA5 in NAFLD livers. Therefore, the correlation between apoA5 and intracellular fat storage is likely explained by the potent effect of apoA5 in promoting intracellular fat storage. Our NAFLD patients and rats had elevated insulin resistance, which may have a role in elevating apoA5 expression in NAFLD livers. Our data support the hypothesis that apoA5 promotes hepatic TG storage and therefore contributes to the pathogenesis of NAFLD, and may represent a potential target for therapeutic intervention.</p> </sec> </abstract>